You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

poziotinib

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

Suspended
  • NSCLC
  • Winter Haven, Florida
    Bond Clinic, P.A.
Jan 27, 2023

EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

Recruiting
  • EGFR Exon 20 Mutation
  • +3 more
  • Poziotinib
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

NSCLC, Breast Cancer Trial in United States (Poziotinib)

Recruiting
  • NSCLC
  • Breast Cancer
  • Poziotinib
  • Long Beach, California
  • +3 more
Jan 7, 2022

Healthy Trial in Tempe (Poziotinib, Itraconazole, Phenytoin)

Completed
  • Healthy
  • Poziotinib
  • +3 more
  • Tempe, Arizona
    Celerion, Phoenix clinical facility
Sep 1, 2021

Breast Cancer Trial in Anaheim, Glendale (Poziotinib, T-DM1)

Terminated
  • Breast Cancer
  • Anaheim, California
  • +1 more
Jan 14, 2021

Breast Cancer Trial in United States (Poziotinib)

Completed
Has Results
  • Breast Cancer
  • Poziotinib
  • Huntsville, Alabama
  • +34 more
Feb 28, 2022

NSCLC Trial in Worldwide (Poziotinib)

Active, not recruiting
  • NSCLC
  • Poziotinib
  • Phoenix, Arizona
  • +62 more
Jan 27, 2023

HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

Completed
  • HNSCC
  • Head and Neck Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2022

Metastatic Breast Cancer Trial in Seoul (Poziotinib)

Completed
  • Metastatic Breast Cancer
  • Poziotinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 1, 2020

NSCLC Trial in China, Korea, Republic of (Poziotinib)

Terminated
  • NSCLC
  • Poziotinib
  • Beijing, China
  • +25 more
Nov 16, 2020

HER2 Gene Mutation, Adenocarcinoma Lung Stage IV Trial in Seoul (Poziotinib)

Completed
  • HER2 Gene Mutation
  • Adenocarcinoma Lung Stage IV
  • Poziotinib
  • Seoul, Korea, Republic of
    Korean Association for the Study of Targeted Therapy
May 23, 2018